EUVIMEDEUVIMED entdecken
Open Access

Outcomes of Supplementation With β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine During Carbon-ion Radiotherapy for Head and Neck Cancer: A Prospective Exploratory Study

Atsushi Musha, Nobuteru Kubo, Masahiro Onishi, Takeru Ohtaka, Tatsuya Ohno

In Vivo · 2026-07 · 40 (4) · 2335-2343

DOI: 10.21873/invivo.14386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, online erschienen am 30.06.2026. Verfasst von Atsushi Musha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan; musha@gunma-u.ac.jp. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Dietary Supplements, Glutamine, Valerates. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsDietary SupplementsGlutamineValeratesArginineHeavy Ion RadiotherapyHumansMaleFemaleMiddle AgedQuality of LifeAgedTreatment OutcomeProspective StudiesAdultMucositis

Stichwörter der Autor:innen

Head and neck cancercarbon-ion radiotherapydermatitismucositisquality of life

Substanzen

GlutamineValeratesArgininebeta-hydroxyisovaleric acid

Autor:innen und Institutionen

  • Gunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan; musha@gunma-u.ac.jp.
  • Department of Oral and Maxillofacial Surgery and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
  • Gunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan.

Zitieren

APA

Musha, A., Kubo, N., Onishi, M., Ohtaka, T., & Ohno, T. (2026). Outcomes of Supplementation With β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine During Carbon-ion Radiotherapy for Head and Neck Cancer: A Prospective Exploratory Study. In Vivo, 40(4), 2335-2343. https://doi.org/10.21873/invivo.14386

Vancouver

Musha A, Kubo N, Onishi M, Ohtaka T, Ohno T. Outcomes of Supplementation With β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine During Carbon-ion Radiotherapy for Head and Neck Cancer: A Prospective Exploratory Study. In Vivo. 2026;40(4):2335-2343. doi:10.21873/invivo.14386

BibTeX
@article{Musha2026,
  author = {Musha, Atsushi and Kubo, Nobuteru and Onishi, Masahiro and Ohtaka, Takeru and Ohno, Tatsuya},
  title = {Outcomes of Supplementation With β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine During Carbon-ion Radiotherapy for Head and Neck Cancer: A Prospective Exploratory Study},
  journal = {In Vivo},
  year = {2026},
  volume = {40},
  number = {4},
  pages = {2335--2343},
  doi = {10.21873/invivo.14386}
}
Kostenlos starten →